Quantifying the Clinical Benefit of Magnetic Resonance Imaging (MRI) in Lung Cancer Radiotherapy

Phase 1

• Conditions: Lung Cancer; Cancer - Lung - Non small cell; ung Cancer

• Registration Number: ACTRN12616001075471
• Lead Sponsor: iverpool Cancer Therapy Centre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-08-10
• Study Completion: 2019-06-08
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

1)Histological or cytological confirmed lung cancer
3)Patient has good renal function ( GFR < 53ml/min)
4)Patient is receiving 12 or more fractions of treatment

Exclusion Criteria

Contraindication to MRI
Prior surgery to area of treatment

Study & Design

• Study Type: Interventional
• Study Design: Not specified